3 ms·
CureVac (mRNA based) didn't get good enough efficacy results, most likely due to the timing with the delta variant. They're working on a new version of the vacc
by scrollaway 5y ago
CureVac (mRNA based) didn't get good enough efficacy results, most likely due to the timing with the delta variant. They're working on a new version of the vaccine which targets that variant specifically and which will be available next year.